Maker Of EpiPen Hit With Fraud & Racketeering Lawsuit Over Price Gouging

A group of EpiPen purchasers have hit drug maker Mylan with a class-action lawsuit, claiming the company engaged in illegal price fixing to inflate the price of its allergy treatment over a decade by 574 percent.